Taylor Wealth Management Partners’s Novavax NVAX Stock Holding History

Taylor Wealth Management Partners’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-61,538	Closed	-$361K	–	48
2019 Q2	$361K	Sell	61,538 -457	-0.7%	-$3.6K	0.17%	40
2019 Q1	$683K	Sell	61,995 -600	-1%	-$18.9K	0.34%	35
2018 Q4	$2.3M	Sell	62,595 -5	-0%	-$194	1.33%	24
2018 Q3	$2.35M	Sell	62,600 -225	-0.4%	-$6.34K	1%	31
2018 Q2	$1.68M	Buy	62,825 +34,540	+122%	+$1.17M	0.75%	37
2018 Q1	$1.19M	Buy	+28,285	New	+$1.14M	0.57%	38

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Taylor Wealth Management Partners's NVAX Position: Q3 2019 in Review

Taylor Wealth Management Partners sold out of Novavax (NVAX) in Q3 2019, closing a stake of 61,538 shares — an estimated $361K sold.

Taylor Wealth Management Partners first reported a position in NVAX in Q1 2018 and held it in 6 quarters. The position peaked at $2.35M in Q3 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q3 2019.

Taylor Wealth Management Partners reported no remaining Novavax position as of Q3 2019 after selling out during the quarter.
Taylor Wealth Management Partners sold 61,538 Novavax shares in Q3 2019, an estimated $361K.
Taylor Wealth Management Partners first reported a position in Novavax in Q1 2018 and held it in 6 quarters.
Taylor Wealth Management Partners's Novavax position peaked at $2.35M in Q3 2018.
81 funds tracked by Wall St. Rank held Novavax as of Q3 2019.

Based on Taylor Wealth Management Partners's 13F filing for Q3 2019, filed 17 Oct 2019.